The impact of diabetes mellitus on peritoneal dialysis: The Turkey Multicenter Clinic Study

Renal Failure

Volumn 36, Issue 2, 2014, Pages 149-153

  Ozener, Cetin ^a   Arikan, Hakki ^b   Karayaylali, Ibrahim ^a   Utas, Cengiz ^a   Bozfakioglu, Semra ^a   Akpolat, Tekin ^a   Ataman, Rezzan ^a   Ersoy, Fevzi ^a   Camsari, Taner ^a   Yavuz, Mahmut ^a   Akcicek, Fehmi ^a   Yilmaz, M Emin ^a  

^a Turkish Multicenter Peritoneal Dialysis Study Group   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diabetes mellitus; Mortality; Peritoneal dialysis; Peritonitis rate

Indexed keywords

SERUM ALBUMIN;

AGING; ALBUMIN BLOOD LEVEL; AMPUTATION; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERITONEAL DIALYSIS; PERITONITIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TURKEY (REPUBLIC);

ADULT; AGED; AMPUTATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PERIPHERAL ARTERIAL DISEASE; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SURVIVAL RATE; TURKEY;

EID: 84896732401     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.843275     Document Type: Article

References (34)

1. Shiao CC, Kao TW, Hung KY, et al. Seven-year follow-up of peritoneal dialysis patients in Taiwan. Perit Dial Int. 2009;29: 450-457.
2. Portole's J, Corchete E, Lo'pez-Sa'nchez P, et al. Patients on peritoneal dialysis with type 2 diabetes present poorer progress than non-diabetics at the expense of their cardiovascular comorbidity. Nefrologia. 2009;29:336-342.
3. Garci'a-Lo'pez E, Carrero JJ, Suliman ME, Lindholm B, Stenvinkel P. Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis. Perit Dial Int. 2007;27:s205-s209.
4. Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis. 2008;51:s1-s320.
5. Saha H, Leskinen Y, Salenius P, Lahtela T. Peripheral vascular disease in diabetic peritoneal dialysis patients. Perit Dial Int. 2007; 27:s211-s214.
6. Chow KM, Szeto CC, Leung CB, Kwan BC, Law MC, Li PK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int. 2005;25:374-379.
7. Oo TN, Roberts TL, Collins AJ. A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis. 2005;45:372-380.
8. Han SH, Lee SC, Ahn SV, et al. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int. 2007;27:432-340.
9. Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol. 2009;4:1195-2000.
10. Golper TA, Brier ME, Bunke M, et al. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis. 1996;28:428-436.
11. Rodri'guez-Carmona A, Pe'rez Fonta'n M, Garci'a Falco'n T, Ferna'ndez Rivera C, Valde's F. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis. Perit Dial Int. 1999;19:253-258.
12. de Fijter CW, Oe LP, Nauta JJ, et al. Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med. 1994;120: 264-271.
13. Ono K, Tsuchida A, Kawai H, et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol. 2003;14:1591-1598.
14. Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis. 1996;27:668-672.
15. Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull. 1987;17:138.
16. Chung SH, Heimbu?rger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005;20:1207-1213.
17. Gloor HJ. 20 years of peritoneal dialysis in a mid-sized Swiss hospital. Swiss Med Wkly. 2003;133:619-624.
18. USRDS: the United States Renal Data System. Am J Kidney Dis. 2003;42:s1-s230.
19. Shinzato T, Nakai S, Akiba T, et al. Current status of renal replacement therapy in Japan: results of the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant. 1997;12:889-898.
20. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int. 2006;70:55-62.
21. Li PK, Law MC, Chow KM, et al. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study. Am J Kidney Dis. 2002;40:373-380.
22. Kim DK, Yoo TH, Ryu DR, et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int. 2004;24: 424-432.
23. Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis - associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant. 2004;19:2584-2591.
24. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int. 2009;29:297-302.
25. Johnson D, Excell L, Livingston B, Bannister K, McDonald S. Chapter 6: peritoneal dialysis. In: McDonald S, Excell L, Livingston B, eds. The Thirty First Report-Australia and New Zealand Dialysis and Transplant Registry: 2008. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2008:6-1-6-20. Available at: http://www.anzdata.org.au/v1/report- 2008.html. Accessed March 15, 2013.
26. Martin C, Montes R, Guerrero A, Lopez R, Cabello V, Bernal G. Peripheral vascular disease in CAPD. Perit Dial Int. 1996;16: 529-531.
27. Lestinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis. 2002;40:472-579.
28. Fung F, Sherrard DJ, Gillen DL, et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis. 2002;40:307-314.
29. Abbott KC, Oliver DK, Hurst FP, Das NP, Gao SW, Perkins RM. Body mass index and peritoneal dialysis: ''exceptions to the exception'' in reverse epidemiology? Semin Dial. 2007;20: 561-565.
30. Zhou H, Cui L, Zhu G, et al. Survival advantage of normal weight in peritoneal dialysis patients. Ren Fail. 2011;33(10):964-968.
31. Duong U, Mehrotra R, Molnar MZ, et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol. 2011;6:1041-1048.
32. Chen KH, Lin JL, Lin-Tan DT, et al. Glycated hemoglobin predicts mortality in nondiabetic patients receiving chronic peritoneal dialysis. Am J Nephrol. 2010;32:567-574.
33. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010; 362:800-811.
34. Sharif A, Baboolal K. Diagnostic application of the A[1c] assay in renal disease. J Am Soc Nephrol. 2010;21:383-385.